We also have 20 children who are GH deficient and on treatment that are participants in another study. These children were evaluated prior to the initiation of treatment. All are scheduled to be re-evaluated at least twice in a five-year period. The data on the first 8 treated children were reported above. These children will serve as important "disease controls".